Citi’s Geoff Meacham on Eli Lilly’s stock climbing as weight loss pill clears latest trial

Geoff Meacham, Citi Research Managing Director, joins ‘Fast Money’ to talk competition in the weight loss drug space as Eli Lilly’s weight loss pill clears its latest trial.